{"schema_version":"1","generated_at":"2026-11-03T00:08:55.236Z","data_as_of":null,"url":"https://www.findmykol.com/kol/jeffrey-wong-ca-2","json_url":"https://www.findmykol.com/kol/jeffrey-wong-ca-2/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"jeffrey-wong-ca-2","name":"Jeffrey Wong","credential":"MD","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Duarte","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1699707893"},"summary":"Jeffrey Wong is an Oncology physician. ClinicalTrials.gov lists 17 registered studies matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"note":"Research metrics are not shown for this record: either no confident publication match for this name, or more than one clinician shares the matched author record."},"trials":{"count":17,"shown":3,"withheld":15,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07608627","title":"64Cu-DOTA A2 scFv-Fc2 DM With Positron Emission Tomography for the Imaging of Patients With Locally Advanced or Metastatic PSCA-Expressing Pancreatic Cancer","phase":"PHASE1","status":"NOT_YET_RECRUITING","role":"Overall official","sponsor":"City of Hope Medical Center","source_url":"https://clinicaltrials.gov/study/NCT07608627","trial_url":"https://www.findmykol.com/trial/NCT07608627"},{"nct":"NCT06580015","title":"[18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer","phase":"NA","status":"ACTIVE_NOT_RECRUITING","role":"Overall official","sponsor":"City of Hope Medical Center","source_url":"https://clinicaltrials.gov/study/NCT06580015","trial_url":"https://www.findmykol.com/trial/NCT06580015"},{"nct":"NCT06287944","title":"225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome","phase":"PHASE1","status":"RECRUITING","role":"Overall official","sponsor":"City of Hope Medical Center","source_url":"https://clinicaltrials.gov/study/NCT06287944","trial_url":"https://www.findmykol.com/trial/NCT06287944"}],"source":"trials"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":3,"shown":3,"withheld":0,"rows":[{"payer":"Accuray Incorporated","program_year":2024,"amount_usd":506.37,"payment_count":6,"source_url":"https://openpaymentsdata.cms.gov/search?query=1699707893"},{"payer":"RefleXion Medical, Inc.","program_year":2023,"amount_usd":213,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1699707893"},{"payer":"RefleXion Medical, Inc.","program_year":2022,"amount_usd":166.42,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1699707893"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1699707893","source":"payments"},"prescribing":{"data_year":2024,"areas_total":1,"areas_shown":1,"areas":[{"area":"Genitourinary & hormones","share_pct":100,"classes_total":1,"classes":[{"class":"alpha-Adrenergic Blocker","setting":"prescribed","share_pct":100,"drugs":[{"name":"Tamsulosin Hcl","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"funding":{"award_count":9,"fiscal_years":{"first":1991,"last":2026},"rows_total":73,"shown":3,"withheld":70,"matched_by":"principal investigator name at an organization in the practice state","rows":[{"project":"R01CA292596","title":"Anti-CD38 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Myelogenous Leukemia","fiscal_year":2026,"amount_usd":"738698","organization":"BECKMAN RESEARCH INSTITUTE/CITY OF HOPE","source_url":"https://reporter.nih.gov/quickSearch/R01CA292596"},{"project":"R01CA283603","title":"Targeted radiation and immunocytokine therapy for CEA positive malignancies","fiscal_year":2026,"amount_usd":"676263","organization":"BECKMAN RESEARCH INSTITUTE/CITY OF HOPE","source_url":"https://reporter.nih.gov/quickSearch/R01CA283603"},{"project":"R01CA292596","title":"Anti-CD38 Radioimmunotherapy and Total Marrow Irradiation for Treatment of Relapsed and Refractory Acute Myelogenous Leukemia","fiscal_year":2025,"amount_usd":"738698","organization":"BECKMAN RESEARCH INSTITUTE/CITY OF HOPE","source_url":"https://reporter.nih.gov/quickSearch/R01CA292596"}],"source":"grants"},"contact":{"address_1":"1500 E DUARTE RD","city":"Duarte","state":"CA","zip":"91010","phone":"626-359-8111","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1699707893","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"trials":15,"funding":70}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2020-11-23","provider_certified":"2020-11-23","collected_at":"2026-11-02T00:00:00.000Z"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024},"grants":{"name":"NIH RePORTER","url":"https://reporter.nih.gov","provides":"Federally funded research awards, by fiscal year"}},"methodology_url":"https://www.findmykol.com/about#methodology"}